Intensity modulated radiotherapy (IMRT) the white, black and grey: A clinical perspective

Reports of Practical Oncology and Radiotherapy

Volumn 14, Issue 3, 2009, Pages 95-103

  Bindhu, Joseph ^a   Supe, Sanjay ^a,b   Pawar, Yeshwanth ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b NONE   (India)

Author keywords

Advances in radiotherapy; Conformal radiotherapy; Dose optimization; Intensity modulated radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BREAST CARCINOMA; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DOSIMETRY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; TREATMENT PLANNING;

EID: 70350113450     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(10)60101-0     Document Type: Review

References (43)

1. Pickett B, Vigeneault E, Kurhanewicz J et al: Static field intensity modulation to treat dominant interaprostatic lesion to 90 Gy compared to seven field 3 dimensional radiotherapy. Int J Radiat Oncol Biol Phys 1999; 44: 921-929 (Pubitemid 29284143)
2. Roeske JC, Lujan A, Romesch J et al: Intensity modulated whole pelvic radiotherapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000; 48: 1613-1621 (Pubitemid 30838394)
3. Portelance I, Chao KS, Grisby PW et al: Intensity modulated Radiotherapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001; 51: 261-266
4. Loyc, Yasuda G, Fitzgerald TJ et al: Intensity modulation for breast treatment using static multileaf collimators. J Radiat Oncol Biol Phys 2000; 46: 187-194
5. Hartmans CW, Chao BCJ, Damen MF et al: Reduction of Cardiac and Lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002; 62: 127-136
6. Krueger EA, Froagss BS, Mc Chan DI et al: Potential gain for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56: 1023-1037
7. Vlani FA, Sharpe M, Kestin L et al: Optimizing Breat Cancer treatment efficacy with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54: 1336-1344 (Pubitemid 35380033)
8. Zelefsky MJ, Fuks Z, Hunt M et al: High dose intensify modulated radiotherapy for prostate cancer: Early toxicity and Biochemical outcome in 771 patients. Int J Radiat Oncol Biol Phys 2002; 53: 1111-1116
9. Dasarahally SM, Kupelian PA, Willoughy TR: Short Course Intensity Modulated Radiotherapy for localized Prostate Cancer with daily Trans-abdominal ultrasound localization of prostate gland. Int J Radiat Oncol Biol Phys 2000; 46: 575-580
10. Kupelian PA, Reddy CA, Klein EA et al: Short Course Intensity Modulated Radiotherapy(70 Gy at 2.5 Gy/Fr) for localized prostate cancer: Preliminary results on late toxicity on Quality of life. Int J Radiat Oncol Biol Phys 2001; 51: 988-993
11. Kupelian PA, Reddy CA, Carlson TP et al: Preliminary Observation on Biochemical relapse free survival rates after short course Intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 275
12. Djemil T, Reddy CA, Willouby TR et al: Hypofractionated Intensity modulated radiotherapy. (70 Gy at 2.5Gy/Fr) for localized prostate cancer (Abstract). Int J Radiat Oncol Biol Phys 2003; 57: 275
13. Combs SF, Koonkel S, Schulz-Ertner D et al: Intensity Modulated Radiotherapy (IMRT) in patients with carcinomas of Paranasal sinusus: Clinical Benefit for complex shaped target volumes. Radiat Oncol 2006; 1: 23
14. Hoppe BS, Stegman LD, Zelefsky MJ et al: Treatment of Nasal Cavity and Paranasal Sinus Cancer with modern radiotherapy techniques in the post operative setting - The MSKCC experience. Int J Radiat Oncol Biol Phys 2007; 67: 691-702
15. Chao KSC, Majharl N, Huang CJ et al: Intensity Modulated Radiotherapy reduces late salivary toxicity without compromising tumor control in patient with Oropharyngeal carcinoma; A comparison with conventional technique. Radiat Oncol 2001; 61: 275-280
16. Chao KSC, Deasy Jo, Markman J et al: A prospective study of salivary function sparing in patients with Head and Neck cancers receiving Intensity Modulated Radiotherapy or 3 Dimensional radiotherapy: Initial Results. Int J Radiat Oncol Biol Phys 2001; 49: 907-916
17. Hall EJ, Woo CS: Radiation Induces Second Cancers. The impact of 3DCRT & IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83-88
18. Kavanagh B, Shefter TE, Wu Q et al: Clinical Application of Intensity Modulated Radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002: 12: 260-271 (Pubitemid 34755932)
19. Schefter TE, Kavanagh BD, Wu Q et al: Technical consideration in the application of Intensity Modulated Radiotherapy as a concomitant integrated boost for locally advanced cervix cancer. Med Dosim 2002; 1: 195-196
20. Roeske JC: Could Intensity Modulated Radiotherapy replace brachytherapy in the treatment of cervical cancer? Brachyther J 2002; 1: 194-195
21. Haslam JJ, Lujan AT, Mundt AJ, Bonta DV, Roesce JC: Set up errors in patients treated with whole pelvic radiation therapy for gynecological Malignacies. Med Dosim 2005; 30(1): 36-42
22. Manje ML, Mizumatsu S, Fike JR et al: Irradiation induces neural precursor cell dysfunction. Nat Med 2002; 8: 955-962
23. Morris DE: Clinical experience with retreatment for palliation. Semin Radiat Oncol 2000; 10: 210-221
24. Kwong DL, Sham JS, Leung LH et al: Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;64 (2): 374-381
25. Gregoire V, De Neve W, Eisbruch A, Lee N, Van den Weyngaert D, Van Gestel D: Intensity Modulated Radiation Therapy for Head and Neck Carcinoma. Oncologist 2007; 12(5): 555-564
26. Zelefsky MJ, Fuks Z, Leibel SA: Intensity Modulated Radiation Therapy for prostate cancer. Sem Radiant Oncol 2002; 12(3): 229-237 (Pubitemid 34755929)
27. Kiffer JD, Berlangieri SU, Scott AM et al: The contribution of 18F - Fluro - 2- deoxy glucose positron emission tomographic imaging to radiotherapy planning in Lung Cancer. Lung Ca 1998; 19(3): 167-177
28. Gambbir SS, Czerina J, Schwimmer J et al: A tabulated summary of the 18 FDG PET literature. J Nucl Med 2002; 42 (5 Suppl): IS-93S
29. Mazen-El-Bassiouni M, Ciernik IF, Davis JB et al: 18 FDG PET -CT Bases Intensity Modulated Tadiotherapy Treatment Planning of Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2007; 1: 286-293
30. Paulino AC, Johnstone PA: FDG PET in radiotherapy treatment planning: Pandara Box? Int J Radiat Oncol Biol Phys 2004;59: 4-5
31. Alber M, Paulsen F, Eschmann SM, Machulla HJ: On Biologically conformal Boost dose Optimization. Phys Med Biol 2003; 48: N31-5 (Pubitemid 36204163)
32. Van Herk M, Remeijer P, Rasch L et al: The probability of correct target dosage: Dose population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47(4): 1121-1135 (Pubitemid 30345614)
33. Austin - Seymour N, Kalet LS, Mc Donald J et al: Three dimensional planning target volumes: A model and a software tool. Int J Radiat Oncol Biol Phys 1995; 33: 1073-1080
34. International Commission on Radiation Units and Measurements prescribing Recording and Reporting photon beam therapy (supplement to ICRU 50) Report 62. Bethseda MD: International Commission on Radationa Units and Measurements 1999
35. Brenner DJ, Martinez AA, Edmundson GK et al: Direct Evidence that Prostate tumor show high sensitivity to fractionation (Low Alpha/Beta) similar to late responding normal tissue. Int J Radiat Oncol Biol Phys 2002; 53: 6-13
36. Fowler JF, Ritter MA, Chapell RJ et al: What hypofractionated protocols should be tested for Prostatic cancer? Int J Radiat Oncol Biol Phys 2003; 56: 1093-2004
37. Wanj JZ, Guerrero M, Li XA: How low is the alpha/beta ratio for prostste cancer? Int J Radiat Oncol Biol Phys 2003; 55: 194-203
38. D' Souza WD, Thames HD: Is the alpha/beta ratio for prostate cacner low? Int J Radiat Oncol Biol Phys 2001; 51: 1-3
39. Wanj JZ, Li XA, Yu CH et al: The low alpha/beta ratio for prostate cancer: What doses the clinical outcome of HDR Brachythearopy tell us? Int J Radiat Oncol Biol Phys 2003: 57: 1101-1108
40. Followill D, GessD, Boyer A: Estimation of whole body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997; 38: 667-672 (Pubitemid 27305029)
41. Williams PO, Hoonsell AR: Xray leakage considerations for IMRT. Br J Radiat 2005; 74: 98-100
42. Waller EJ: Neutron Production associated with Radiotherapy Linear acceleratos using intensity modulated radiation therapy mode. Health Phys 2003;85 (5 Suppl): 575-577
43. Hall EJ, Woo CS: Radiation Induced Second Cancer. The impact of 3DCRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83-88